• DRAMP ID

    • DRAMP18081
    • Name

    • PAC113
    • Sequence

    • AKRHHGYKRKFH
    • Description

    • based on the active segment of histatin 5 protein found in human saliva
    • Activity

    • Antifungal
    • Target Organism

      • No MICs found on DRAMP database
    • Reference

      • Not available
    • Medical use

    • Oral candidiasis in HIV seropositive patients
    • Company

    • Pacgen(Vancouver, BC, Canada)
    • Stage of Development

    • Phase IIb
    • Comments

    • Current treatments for Candida infections are either only marginally efficacious, have poor patient compliance characteristics, can cause serious side effects, can lead to drug-resistance and/or have multiple drug interaction issues.Phase IIb results: 34% increase in primary end point efficacy level; Phase III trial not initiated
    • Clinical Trials

    • NCT00659971